REG - Directa Plus PLC - Notice of Results Presentations

Directa PlusAnnouncement

27/04/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230427:nRSa6168Xa&default-theme=true

RNS Number : 6168X  Directa Plus PLC  27 April 2023

27 April 2023

 

Directa Plus plc

("Directa Plus", the "Company" or the "Group")

 

 

Notice of Results Presentations

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets, is
pleased to announce that following the release of its Final Results on 10 May
2023, management will host a live virtual presentation and Q&A for
analysts at 9am on the morning on results, and a live virtual presentation and
Q&A for retail investors on 12 May 2023 at 1.30pm.

 

Both presentations will be given by Giulio Cesareo - Chief Executive Officer,
and Giorgio Bonfanti - Chief Financial Officer.

 

Questions can be submitted at any time during the live presentations.

 

A recording of the presentation will be made available on the Company's
website following the conclusion of the investor presentation.

 

Analyst Presentation

 

To register to attend, please email directaplus@almapr.co.uk
(mailto:directaplus@almapr.co.uk)

 

Retail Investor Presentation

 

To register to attend, please use the following link:
https://www.investormeetcompany.com/directa-plus-plc/register-investor
(https://www.investormeetcompany.com/directa-plus-plc/register-investor)

 

 

Enquiries

 

 Directa Plus plc                                             +39 02 36714458

 Giulio Cesareo, CEO                                          www.directa-plus.com

 Giorgio Bonfanti, CFO

 Cenkos Securities plc (Nominated Adviser and Joint Broker)   +44 131 220 6939

 Neil McDonald

 Adam Rae

 Singer Capital Markets Securities Limited (Joint Broker)     +44 20 7496 3069

 Rick Thompson

 Phil Davies

 Alma PR (Financial PR Adviser)                               +44 20 3405 0205

 Justine James

 Hannah Campbell

 Kinvara Verdon

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products.  Directa Plus' products are made of hybrid graphene
materials and graphene nano-platelets. The products (marketed as G+®) have
multiple applications due to their properties. These G+® products can be
categorised into various families, with different products being suitable for
specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
Directa Plus holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORPPUPGCUPWPGQ